-
DE
CTLA-4 Blockade: Immune Checkpoint Therapy
CTLA-4 blockade is a form of immune checkpoint therapy that enhances the immune system to fight cancer cells. It is primarily used in oncology.
Add as Preferred SourceThings worth knowing about "CTLA-4 Blockade"
CTLA-4 blockade is a form of immune checkpoint therapy that enhances the immune system to fight cancer cells. It is primarily used in oncology.
What is CTLA-4 Blockade?
CTLA-4 blockade is an immunotherapeutic strategy that targets and inhibits the molecule CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4). CTLA-4 is an immune checkpoint – a regulatory mechanism that normally suppresses the activity of T-lymphocytes (white blood cells). By blocking this protein, the immune response against tumor cells is significantly enhanced.
Mechanism of Action
T-cells are central components of the body's immune defense. Their activation requires two signals: first, the recognition of an antigen, and second, a co-stimulatory signal triggered by the binding of CD28 to B7-1 or B7-2 molecules on antigen-presenting cells.
CTLA-4 competes with CD28 for the same binding partners (B7-1/B7-2) but has a higher binding affinity. When CTLA-4 binds, T-cell activation is suppressed – a mechanism that under normal conditions prevents excessive immune reactions.
Tumor cells can exploit this mechanism to evade immune recognition. CTLA-4-blocking antibodies (e.g., Ipilimumab) prevent this inhibition, thereby promoting stronger T-cell activation against the tumor.
Clinical Applications
CTLA-4 blockade is primarily used in oncological treatment. Approved indications include:
- Malignant melanoma: Ipilimumab was the first approved CTLA-4 inhibitor.
- Non-small cell lung cancer (NSCLC): in combination with other checkpoint inhibitors.
- Renal cell carcinoma: in combination with PD-1 inhibitors such as Nivolumab.
- Colorectal cancer with microsatellite instability.
- Additional tumor entities within clinical trials.
Combination with Other Immunotherapies
CTLA-4 blockade is frequently combined with PD-1 or PD-L1 inhibitors to achieve a synergistic effect. While CTLA-4 inhibitors act early in the T-cell priming phase, PD-1/PD-L1 inhibitors primarily affect the effector T-cell phase. Combination regimens can significantly improve response rates, but also increase the risk of side effects.
Side Effects
Since CTLA-4 blockade broadly stimulates the immune system, immune-related adverse events (irAEs) can occur:
- Skin: rash, pruritus, vitiligo
- Gastrointestinal tract: diarrhea, colitis
- Liver: hepatitis (elevated liver enzymes)
- Endocrine system: hypophysitis, thyroiditis, adrenalitis
- Lungs: pneumonitis
- Rarely, life-threatening immune reactions
Management of these side effects typically involves corticosteroids or other immunosuppressive agents. In severe cases, treatment must be paused or permanently discontinued.
Dosage and Administration
CTLA-4 inhibitors are administered as intravenous infusions. Ipilimumab is typically given every three weeks, with a standard dose of 3 mg/kg body weight in melanoma. In combination regimens, lower doses (e.g., 1 mg/kg) may be used. The exact dosage always depends on the specific treatment protocol and the disease being treated.
Significance in Modern Oncology
The development of CTLA-4 blockade is considered a milestone in cancer therapy. The discovery of this principle was awarded the Nobel Prize in Physiology or Medicine in 2018 (James P. Allison and Tasuku Honjo). It opened a new era of immuno-oncology and laid the foundation for numerous subsequent checkpoint therapies.
References
- Allison JP. - Checkpoints. - Cell. 2015;162(6):1244-1245. (PubMed)
- Wolchok JD et al. - Nivolumab plus Ipilimumab in Advanced Melanoma. - N Engl J Med. 2013;369(2):122-133.
- European Medicines Agency (EMA) - Yervoy (Ipilimumab) - Product Information. - ema.europa.eu (2024).
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Skip product gallery
Subscription available
Floral
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®30 lozenges
Regular price:
22,90 €
Discount
Subscription available
Lactoferrin 60 Capsules
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
60 Capsules
Sale price:
50,00 €
Regular price:
59,90 €
Discount
Subscription available
Multivitamin Mineral Complex
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
30 Capsules
Sale price:
27,90 €
Regular price:
29,90 €
Subscription available
Natural Iron
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
30 Capsules
Regular price:
35,90 €
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Magnesiumcarbonat ist eine anorganische Magnesiumverbindung mit säure-neutralisierender (antazidischer) Wirkung. Erfahre mehr über Vorteile, Einsatzgebiete und Unterschiede zu besser resorbierbaren Magnesiumformen.
Calorie content
The choice of food influences our energy intake. The calorie content varies greatly - some provide little energy, others a lot.
Cologne list
The Cologne List ® is an important initiative in competitive sports that offers athletes guidance in the selection of nutritional supplements.